Position in VTRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,344,272
-$450,520 QoQ
Shares Held
99,502
-31.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $27,399,554 across 15 Drug Manufacturers - Specialty & Generic names. VTRS ranks #6 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
162,424 | $5,743,312 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
8,887 | $5,269,813 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
36,232 | $4,773,203 | |
| 4 | ZTS |
Zoetis Inc.
|
33,846 | $4,000,935 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
354,260 | $3,372,555 | |
| 6 | VTRS |
Viatris Inc
This page
|
99,502 | $1,344,272 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
216,623 | $760,346 | |
| 8 | EBS |
Emergent BioSolutions Inc.
|
85,199 | $707,151 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,344,272 | 99,502 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,794,792 | 144,160 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,490,296 | 150,535 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,344,161 | 150,522 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,269,883 | 145,796 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,031,678 | 163,187 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,842,274 | 158,680 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,798,021 | 169,146 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,972,237 | 165,179 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,773,748 | 163,781 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,592,912 | 161,553 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,499,644 | 150,265 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,297,353 | 134,860 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,467,267 | 131,830 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $764,457 | 89,725 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $529,551 | 50,578 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $876,384 | 80,550 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,472,781 | 108,853 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,274,892 | 94,088 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $814,872 | 57,024 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $690,383 | 49,419 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $895,284 | 47,774 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||